coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Medway Peninsula PCN, Medway (LAD) · Health Inequalities Profile

    PCN U56757 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    39,531

    Registered population

    57.8% aged 18–64

    21.7%

    Aged 65+

    ICB 19.9% · England 17.9%

    14.2%

    Ethnic minority (non-White)

    6.0% Asian · England 9.6%

    2.5%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~1,078

    Core20 residents (est.)

    Resident basis; registered basis ~1,028 · see page 3

    7,466

    Hypertension register

    +6.36% in 3 yrs · England +5.60%

    350

    SMI register

    12.3% of Medway (LAD)'s

    823

    COPD register

    Reviews -11.49% in 3 yrs

    Forecast to 2030

    9,221

    Hypertension patients, 2030

    +1,755 on today

    71.5%

    QRISK ≥20% on statins, 2030

    +2.36pp over 3 yrs

    5.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.2%
    Asthma annual reviews trail England and fell sharply.

    Only 52.2% of asthma patients had a review (England 65.7%), a -10.7% three-year change leaving an estimated 1,194 register scale gap.

    73.6%
    SMI blood pressure checks and hypertension control lag.

    SMI blood pressure checks reached 73.6% (England 83.4%, three-year change -6.3 pp), while hypertension treatment to target sits at 64.5% (England 70.3%).

    66.5%
    Lipid therapy and statin prescribing exceed national averages.

    Lipid-lowering therapy for QRISK ≥ 20% reaches 66.5% (England 63.6%), and statin treatment in diabetes without CVD reaches 75.8% (England 73.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ account for 21.7% of the list, above Medway and England

    Across 39,531 registered patients, 21.7% (8,591) are aged 65+, higher than Medway (17.9%), the ICB (19.9%) and England (17.9%). The 18–64 group comprises 57.8% (Medway 60.4%, ICB 59.5%, England 62.7%), while under-18s represent 20.4% (Medway 21.6%, ICB 20.7%, England 19.6%). Census resident estimates show 85.8% White ethnicity (Medway 84.3%, ICB 88.6%, England 81.1%) and 14.2% ethnic minorities, though resident Census profiles differ from GP registrations. List growth is projected at 9.1% to 2030 (Medway 7.0%, ICB 6.0%, England 2.3%), under an unverified methodology.

    Age profile

    0–1720.4%
    18–6457.8%
    65+21.7%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White85.8%
    Asian6.0%
    Black4.3%
    Mixed2.5%
    Other1.3%

    Older people · falls rows are Medway (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Medway LA)1,5072,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Medway LA)7409819552024/25
    Falls deaths, all ages, per 100,000 (Medway LA)19.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 2.5% overall and concentrated entirely within Thorndike Partnership

    Core20 deprivation is 2.5%, below Medway LAD (23.1%), NHS Kent and Medway ICB (17.1%) and England (21.0%). Deprivation concentrates in Thorndike Partnership (8.6% share, estimated 1,028 patients); The Elms Medical Centre and Highparks Medical Practice record 0.0% (0.12 pp reconciliation difference versus 1,078 resident estimate). Across 350 severe mental illness patients network-wide, blood pressure checks fell 6.3 pp to 73.6% (England +4.4 pp) and BMI checks fell 6.8 pp to 68.5% (England +5.1 pp). Core20 deprivation is concentrated at Thorndike Partnership, while network-wide SMI physical checks lag national trends.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Thorndike8.6% · 1,028 patients
    Elms0.0% · 0 patients
    Highparks Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    350

    SMI register

    0.87% recorded prevalence

    201

    Learning disability register

    0.50% recorded prevalence

    21

    Care homes, 549 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Medway (LAD), Census 2021

    Learning disability prevalence is 0.5% (201 patients; Medway 0.7%, ICB 0.6%, England 0.6%) and severe mental illness is 0.9% (350 patients; Medway 0.9%, ICB 0.9%, England 1.0%). Catchment care homes total 21 (549 beds), with dementia prevalence at 1.0% (401 patients, up +17.4% over three years; Medway 0.6%, ICB 0.8%, England 0.8%).

    Severe mental illness: physical health checks

    SMI blood pressure checks fell 6.3 pp to 73.6% (England 83.4%, +4.4 pp), with The Elms Medical Centre at 58.6% and Highparks Medical Practice at 67.4%. BMI checks fell 6.8 pp to 68.5% (England 82.1%, +5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,466

    Hypertension register

    +6.36%

    Register growth, 3 yrs

    Medway (LAD) +3.74% · England +5.60%

    −3.30pp

    BP control, under 80

    ≤140/90 · −1.36pp aged 80+

    +1,755

    More patients by 2030

    Forecast 9,221 (21.03%)

    Hypertension case-finding and control

    Hypertension register prevalence is 18.6% (7,466 patients), exceeding England (15.2%), Medway (15.4%), and the ICB (16.2%), though crude rates are not age-adjusted. Blood pressure checks reached 87.0% (+2.6 pp over three years; England +3.1 pp). However, patients treated to target fell 3.3 pp to 64.5%, below England (70.3%, +2.5 pp). Control in patients aged under 80 fell 3.3 pp to 61.6% (England 67.8%, +2.1 pp), with The Elms Medical Centre at 58.8% and Highparks Medical Practice at 59.2%.

    Lipids and statins

    For patients with QRISK at or above 20%, lipid-lowering therapy uptake is 66.5%, exceeding England (63.6%), Medway (64.0%), and the ICB (61.4%). Statin coverage in diabetes without CVD also leads comparators at 75.8% (England 73.2%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026102,068£1.40£1.90£1.86£142,895
    Cardiovascular (all), 2025110,441£2.42£3.57£3.33£267,267

    For lipid-regulating drugs in 2026, the PCN prescribed 102,068 items at £1.40 per item, compared to £1.86 in England, £1.87 in Medway, and £1.90 across the ICB. Prescribing spend was £46,951 less than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −10.72%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.08%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.6%, matching England (6.6%), but annual reviews fell 6.3 pp over three years (England +2.8 pp) to 52.2% (England 65.7%), indicating an unreviewed scale gap of 1,194 patients across the 2,496 register. Meanwhile, youth asthma prescribing reached 1,551 items per 1,000 aged 5–19, above England (1,488). Similarly, COPD reviews dropped 11.5% over three years (England +2.8%) to 69.9% (England 76.4%) across 823 patients.

    Cancer register and children's immunisation

    Cancer prevalence is 4.7% (England 3.8%) across 1,905 patients. For childhood immunisations, age-5 MMR dose 1 reaches 97.1% (England 91.7%), exceeding the 95.0% target. However, dose 2 achieves 84.5% (England 82.8%), sitting 10.5 pp below the 95.0% target—a 12.6 pp dose contrast across the PCN cohort, widening to 24 pp at Thorndike Partnership.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.7%

    England 91.0%

    6-in-1 complete primary course at 24 months93.3%

    England 92.2%

    MMR dose 1 at 24 months89.9%

    England 88.3%

    MMR dose 2 at age 584.5%

    England 82.8%

    4-in-1 pre-school booster at age 584.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Across NHS Kent and Medway ICB in 2022, 55.6% of cancers with a known stage (4,661 of 8,384) were diagnosed at stage 1 or 2 (England 55.3%). Known stage was recorded for 63.6% of registered ICB cancers (8,384 of 13,189; England 67.0%). Reaching the 75.0% national ambition requires 1,627 additional early-stage diagnoses annually across the ICB, where early-stage share rose 2.2 pp since 2013. PCN cervical screening coverage is 73.7% (England 66.8%), with The Elms Medical Centre at 70.9%. Three-year change was -1.6% (England -1.0%), with Highparks Medical Practice at -2.7%. Reversing screening declines supports early detection across the network.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At acute provider level for July 2026 (provisional), Medway NHS Foundation Trust achieved 81.6% against the 85.0% 62-day cancer standard, exceeding NHS Kent and Medway Integrated Care Board (75.9%) and England (71.2%), while Maidstone and Tunbridge Wells NHS Trust reached 87.4%. Medway NHS Foundation Trust met the 75.0% faster diagnosis standard at 77.8% (ICB 76.8%, England 79.3%) and reached 99.6% on the 96.0% 31-day standard. For diagnostic waits, 14.2% waited 6+ weeks across all diagnostic tests (England 23.1%), with sleep studies at 90.4% and cardiology echocardiography at 36.6%.

    Pathways within standard (%)MedwayMaidstone and Tunbridge WellsMid and South EssexKent and Medway ICBEngland
    28-day faster diagnosis (75%)77.7781.7867.4576.7879.32
    31-day treatment (96%)99.6298.3581.8895.8492.50
    62-day referral to treatment (85%)81.6487.4350.2575.9371.16
    Diagnostic waits over 6 weeks (%)MedwayMaidstone and Tunbridge WellsMid and South EssexEngland
    MRI0.680.9223.3521.40
    CT0.000.516.079.92
    Echocardiography36.622.5765.0528.48
    Colonoscopy1.8819.8064.0930.83
    Gastroscopy3.3224.0359.7629.02
    All 15 DM01 tests14.206.4241.5423.14
    Community services activityMedway residentsKent and Medway ICB
    Care contacts43,510254,055
    Referrals8,58068,085
    Patients with a contact11,54072,060

    Community services (residents of Medway), Jun 2026 (provisional). At local authority level in June 2026 (provisional experimental data), Medway residents recorded 31,250 community care activities and 43,510 community care contacts, within an ICB total of 297,595 activities. Adults aged 65+ accounted for 62% of Medway residents' community contacts (26,985 of 43,510), describing wider borough community caseload.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, overall QOF achievement reached 95.5% at Highparks Medical Practice, 93.6% at Thorndike Partnership, and 88.5% at The Elms Medical Centre (England 92.5%). In the vaccination and immunisation domain, Highparks Medical Practice achieved 61.4% and Thorndike Partnership reached 45.8% (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Elms980.023.3%62.6%69.2%
    Highparks Medical930.017.1%62.3%54.0%
    Thorndike998.634.6%53.1%42.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNMedway (LAD)AssetPCNMedway (LAD)
    Care homes (catchment)21 (549 beds)n/aSchools (catchment)64n/a
    Children's centres419Places of worship39110
    Libraries39Food banks (VCS)16
    Homelessness support (VCS)n/a9Day centres (VCS)329
    Children and young people (VCS)1265Carers support groups (VCS)1222
    Primary schools (LA maintained)617Primary academies1456

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    Asthma review coverage is 52.2% (falling 6.3 pp; England 65.7%, +2.8 pp), indicating a scale gap of 1,194 unreviewed patients across the 2,496 register. For discussion, practices could run structured annual review recalls using shared templates and flexible slots, prioritising Thorndike Partnership (8.6% Core20 share, 1,028 estimated patients). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined SMI physical health checks

    Across 350 SMI patients, annual BP checks reached 73.6% (9.8 pp below England's 83.4%, falling 6.3 pp) and BMI checks 68.5% (13.6 pp below England's 82.1%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pharmacist-led hypertension titration reviews

    Across 7,466 hypertension patients (18.6% prevalence), treatment to target is 64.5% (5.8 pp below England's 70.3%, falling 3.3 pp) and under-80 control is 61.6% (England 67.8%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult capacity planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)—Practice
    Option 1 · Structured asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Combined SMI physical health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Option 3 · Pharmacist-led hypertension titration reviews (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15